Intranasal Salcatonin (Salmon Calcitonin)
- 1 May 1996
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 8 (5) , 378-400
- https://doi.org/10.2165/00002512-199608050-00006
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Analgesic effect of two calcitonins and in vitro interaction with opioidsGeneral Pharmacology: The Vascular System, 1995
- A 5‐year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calciumEuropean Journal of Clinical Investigation, 1994
- Calcitonin and its antinociceptive activity: Animal and human investigations 1975–1992Inflammation Research, 1994
- The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal womenGynecological Endocrinology, 1994
- Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJournal of Bone and Mineral Research, 1994
- Perspective how many women have osteoporosis?Journal of Bone and Mineral Research, 1992
- Intranasal Salmon CalcitoninDrugs & Aging, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Salmon calcitonin given by nasal spray or by injection does not increase β-endorphin levels in normal menLife Sciences, 1990
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989